View in EDS HTML Full Text PDF Full Text

Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice.

Saved in:
Bibliographic Details
Title: Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice.
Authors: Monteagudo, Vinícius1,2 (AUTHOR), Flores, Larissa Cristina Barbosa1,2 (AUTHOR), Lopes, Melaine1,2,3 (AUTHOR), Fachel, Flavia Nathiely Silveira1,4 (AUTHOR), Martins, Giselle1,2 (AUTHOR), Siebert, Marina2 (AUTHOR), Carniel, Willian da Silva1,2,3 (AUTHOR), Garcez, Tuane Nerissa Alves2,4 (AUTHOR), Teixeira, Helder Ferreira1 (AUTHOR), Matte, Ursula2,3 (AUTHOR), Giugliani, Roberto2,3 (AUTHOR), Baldo, Guilherme2,3 (AUTHOR), Poletto, Édina4 (AUTHOR), Schuh, Roselena Silvestri1,2 (AUTHOR) roselena.schuh@ufrgs.br
Source: Pharmaceutics. May2025, Vol. 17 Issue 5, p656. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994923
DOI:10.3390/pharmaceutics17050656